Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O7IZ
|
||||
Former ID |
DIB001369
|
||||
Drug Name |
Anti-MIF antibodies
|
||||
Synonyms |
Antimacrophage inhibitory factor, Baxter; Anti-MIF antibodies (inflammation); Anti-MIF antibodies (inflammation), Baxter; Anti-MIF technology, Cytokine/IDEC; Anti-inflammatories, Cytokine/IDEC; Anti-macrophage inhibitory factor, Cytokine/IDEC
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Phase 4 | [523659] | ||
Company |
Baxter healthcare
|
||||
Target and Pathway | |||||
Target(s) | Macrophage migration inhibitory factor | Target Info | Inhibitor | [544220] | |
KEGG Pathway | Tyrosine metabolism | ||||
Phenylalanine metabolism | |||||
PathWhiz Pathway | Tyrosine Metabolism | ||||
WikiPathways | Spinal Cord Injury | ||||
Adipogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.